Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16720669 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors
Conditions: Hypogonadism;   Erectile Dysfunction
Intervention: Drug: Fispemifene (once daily for 8 weeks)

Indicates status has not been verified in more than two years